296 related articles for article (PubMed ID: 33528317)
1. Long non-coding RNA ANRIL and its target microRNAs (microRNA-34a, microRNA-125a and microRNA-186) relate to risk stratification and prognosis in multiple myeloma.
Yin Y; Yang W; Zhang L; Liu K; Luo Z
Hematology; 2021 Dec; 26(1):160-169. PubMed ID: 33528317
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA ANRIL interacts with microRNA-34a and microRNA-125a, and they all correlate with disease risk and severity of Parkinson's disease.
Yang P; Lin G; Wang M; Chen X; Huang J
J Clin Lab Anal; 2022 Jan; 36(1):e24037. PubMed ID: 34921567
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA NEAT1 serves as a novel biomarker for treatment response and survival profiles via microRNA-125a in multiple myeloma.
Yu H; Peng S; Chen X; Han S; Luo J
J Clin Lab Anal; 2020 Sep; 34(9):e23399. PubMed ID: 32608537
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of LncRNA ANRIL mediated by miR-411-3p inhibits the malignant proliferation and tumor stem cell like property of multiple myeloma via hypoxia-inducible factor 1α.
Wang M; Zhao HY; Zhang JL; Wan DM; Li YM; Jiang ZX
Exp Cell Res; 2020 Nov; 396(1):112280. PubMed ID: 32961145
[TBL] [Abstract][Full Text] [Related]
5. LncRNA ANRIL/miR-125a axis exhibits potential as a biomarker for disease exacerbation, severity, and inflammation in bronchial asthma.
Ye S; Zhu S; Feng L
J Clin Lab Anal; 2020 Mar; 34(3):e23092. PubMed ID: 31821602
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a.
Hu X; Jiang H; Jiang X
Cancer Biol Ther; 2017 May; 18(5):331-338. PubMed ID: 28402230
[TBL] [Abstract][Full Text] [Related]
7. LncRNA ANRIL promotes cell proliferation, migration and invasion during acute myeloid leukemia pathogenesis via negatively regulating miR-34a.
Wang CH; Li QY; Nie L; Ma J; Yao CJ; Chen FP
Int J Biochem Cell Biol; 2020 Feb; 119():105666. PubMed ID: 31830533
[TBL] [Abstract][Full Text] [Related]
8. Lncrna ANGPTL1-3 and its target microRNA-30a exhibit potency as biomarkers for bortezomib response and prognosis in multiple myeloma patients.
Zhou F; Guo L
Hematology; 2022 Dec; 27(1):596-602. PubMed ID: 35617291
[TBL] [Abstract][Full Text] [Related]
9. Elevated circulating lnc-ANRIL/miR-125a axis level predicts higher risk, more severe disease condition, and worse prognosis of sepsis.
Gui F; Peng H; Liu Y
J Clin Lab Anal; 2019 Jul; 33(6):e22917. PubMed ID: 31115097
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA ANRIL knockdown suppresses apoptosis and pro-inflammatory cytokines while enhancing neurite outgrowth via binding microRNA-125a in a cellular model of Alzheimer's disease.
Zhou B; Li L; Qiu X; Wu J; Xu L; Shao W
Mol Med Rep; 2020 Aug; 22(2):1489-1497. PubMed ID: 32626959
[TBL] [Abstract][Full Text] [Related]
11. Dynamical Analysis of a Boolean Network Model of the Oncogene Role of lncRNA ANRIL and lncRNA UFC1 in Non-Small Cell Lung Cancer.
Gupta S; Hashimoto RF
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327612
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA NEAT1 correlates with higher disease risk, worse disease condition, decreased miR-124 and miR-125a and predicts poor recurrence-free survival of acute ischemic stroke.
Li P; Duan S; Fu A
J Clin Lab Anal; 2020 Feb; 34(2):e23056. PubMed ID: 31721299
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA_0000190 and its target microRNA-767-5p are dysregulated, and they are related to risk stratification as well as prognosis in multiple myeloma patients.
Xiang Y; Xu X; Yang B; Wu Z; Jiang R; Xie Y
Ir J Med Sci; 2022 Apr; 191(2):671-679. PubMed ID: 33864191
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of long non-coding RNA ANRIL inhibits proliferation, migration, and invasion but promotes apoptosis of human glioma cells by upregulation of miR-34a.
Dong X; Jin Z; Chen Y; Xu H; Ma C; Hong X; Li Y; Zhao G
J Cell Biochem; 2018 Mar; 119(3):2708-2718. PubMed ID: 29057547
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-146b overexpression associates with deteriorated clinical characteristics, increased International Staging System stage, cacoethic chromosome abnormality, and unfavorable prognosis in multiple myeloma patients.
Bao Y; Wei M; Ji X
J Clin Lab Anal; 2020 May; 34(5):e23168. PubMed ID: 31908003
[TBL] [Abstract][Full Text] [Related]
16. Long non‑coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia.
Tan Z; Zhu K; Yin Y; Luo Z
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300059
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of ANRIL aggravates H
Li R; Yin F; Guo YY; Zhao KC; Ruan Q; Qi YM
Biomed Pharmacother; 2017 Aug; 92():952-961. PubMed ID: 28609843
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA NEAT 1 and its target microRNA-125a in sepsis: Correlation with acute respiratory distress syndrome risk, biochemical indexes, disease severity, and 28-day mortality.
Yang Y; Yang L; Liu Z; Wang Y; Yang J
J Clin Lab Anal; 2020 Dec; 34(12):e23509. PubMed ID: 32785981
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-125a attenuates the chemoresistance against ubenimex in non-small cell lung carcinoma via targeting the aminopeptidase N signaling pathway.
Li C; Zhai W; Wan L; Li J; Huang A; Xing S; Fan K
J Cell Biochem; 2020 Feb; 121(2):1716-1727. PubMed ID: 31595566
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA ANRIL down-regulates microRNA-7 to protect human trabecular meshwork cells in an experimental model for glaucoma.
Zhao J; Sun H; Zhang JM; Wang M; Du XJ; Zhang JL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3173-3182. PubMed ID: 31081068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
